← Back to Clinical Trials
Recruiting NCT06096272

NCT06096272 Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06096272
Status Recruiting
Phase
Sponsor Children's Hospital Los Angeles
Condition Cerebral Palsy
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-06-07
Primary Completion 2025-05-31

Eligibility & Interventions

Sex All sexes
Min Age 5 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
Augment Reality Exergames

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2024-06-07 with a primary completion date of 2025-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Children with cerebral palsy (CP), Gross Motor Functional Classification Scale (GMFCS) I-II will be recruited to participate in a home based physical activity intervention for 4 weeks. Demographic data will be collected, and validated surveys assessing baseline physical activity level and mobility will be completed. Participants will have an exercise program assigned and will be given a logbook to record their exercise adherence. They will be assigned to the Augment Reality (AR) app group. The AR app group will have exercises administered through the AR app. At the end of the program, participants will complete final surveys and an exit interview.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of cerebral palsy, * Ambulatory (GMFCS I and II) * English or Spanish speaking * No plans for lower extremity surgery in the next 4 months Exclusion Criteria: * Moderate to severe developmental or cognitive delay * Significant hearing loss or visual impairment * Recent surgical procedure or fracture over the past 4 months that impacts physical activity

Contact & Investigator

Central Contact

Abigail Padilla, BS

✉ OrthoResearch@chla.usc.edu

📞 323-361-2142

Principal Investigator

Melissa Bent, MD

PRINCIPAL INVESTIGATOR

Children's Hospital Los Angeles

Frequently Asked Questions

Who can join the NCT06096272 clinical trial?

This trial is open to participants of all sexes, aged 5 Years or older, up to 18 Years, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06096272 currently recruiting?

Yes, NCT06096272 is actively recruiting participants. Contact the research team at OrthoResearch@chla.usc.edu for enrollment information.

Where is the NCT06096272 trial being conducted?

This trial is being conducted at Los Angeles, United States.

Who is sponsoring the NCT06096272 clinical trial?

NCT06096272 is sponsored by Children's Hospital Los Angeles. The principal investigator is Melissa Bent, MD at Children's Hospital Los Angeles. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology